Structure Therapeutics Inc.
GPCR
$21.76
$3.2317.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.36% | -30.51% | 0.01% | -6.26% | -2.69% |
| Total Depreciation and Amortization | -3.62% | 18.97% | 4.50% | 149.44% | 7.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.28% | -79.07% | 1,618.95% | -163.89% | -107.68% |
| Change in Net Operating Assets | -103.90% | 773.70% | 75.11% | -400.29% | -1.16% |
| Cash from Operations | -85.15% | 25.37% | 22.56% | -56.84% | -5.70% |
| Capital Expenditure | 97.66% | -60.42% | -163.58% | 85.99% | -40.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.65% | 7.71% | -13,016.96% | 100.88% | -680.27% |
| Cash from Investing | 117.58% | 7.56% | -14,522.78% | 100.78% | -699.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 54.91% | -99.92% | 68,150.60% | -99.75% | 63,349.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -95.93% | -1,011.32% | 99.71% | -- |
| Cash from Financing | 181.24% | -100.15% | 73,219.52% | -99.75% | 59,441.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.75% | -173.82% | 987.97% | -140.38% | 688.01% |